New gene therapy hopes to change lives of children with rare brain disorder

NCT ID NCT07135050

First seen Jan 09, 2026 · Last updated May 24, 2026 · Updated 25 times

Summary

This early-stage trial tests a new gene therapy called MZ-1866 for people with Pitt Hopkins Syndrome, a rare genetic condition that affects development. The study will include 12 children and adults who will receive a single injection of the therapy into the fluid around the brain. Researchers will closely monitor safety and any changes in health or development over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PITT HOPKINS SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Hospital Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Rush University Medical Center

    NOT_YET_RECRUITING

    Chicago, Illinois, 60612, United States

    Contact

    Contact Email: •••••@•••••

  • Sheba Medical Center

    RECRUITING

    Tel Litwinsky, Israel

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • UCSF Benioff Children's Hospital Oakland

    RECRUITING

    Oakland, California, 94609, United States

    Contact

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.